Aldosterone- and cortisol-co-secreting adrenal tumors: an uneasy sum of well-known parts (review)
Problems of Endocrinology · 2019
DOI: 10.14341/probl10036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Problems of Endocrinology, 2019. Verfasst von B M Shifman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Research Centre. Hauptthemen laut MEDLINE: Adrenal Gland Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Primary aldosteronism (PA) is the most common form of secondary arterial hypertension. In patients with PA, more so than in the general population, there is a prevalence of insulin resistance, diabetes mellitus, metabolic syndrome, osteoporosis, and symptoms of depression; these conditions are more likely to manifest a gluco- rather than mineralocorticoid excess. This fact is of particular importance in light of recent studies that have shown that PA is often associated with glucocorticoid excess. Since the first reports of cases of combined secretion of aldosterone and cortisol in 1979, the number of cases of so-called Connshing syndrome has increased. An analysis of data from recent studies suggests that hypercortisolism in PA is closely associated with an increased risk of cardiovascular complications, metabolic disorders and post-surgical adrenal insufficiency. The most important diagnostic problem in adenomas with combined secretion is the risk of false interpretation of the results of adrenal venous sampling (AVS). The indications that suggest aldosterone-and-cortisol-co-producing adenoma are the lack of suppression of cortisol levels following a night test with 1mg of dexamethasone, and an adrenal tumo of over 2.5cm. As an alternative test capable of differentiating this type of tumor, a number of researchers have proposed measuring the level of so-called hybrid steroids in the peripheral plasma and urine. Taking into account the high prevalence and potential risks, ruling out of excess corisol secretion is obligatory in all cases of PA before AVS and when planning surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology Research Centre.
ORCID-Profile: B M Shifman, N M Platonova, N V Molashenko, E A Troshina, N Y Romanova, G S Kolesnikova
Zitieren
APA
Shifman, B. M., Platonova, N. M., Molashenko, N. V., Troshina, E. A., Romanova, N. Y., & Kolesnikova, G. S. (2019). Aldosterone- and cortisol-co-secreting adrenal tumors: an uneasy sum of well-known parts (review). Problems of Endocrinology. https://doi.org/10.14341/probl10036
Vancouver
Shifman BM, Platonova NM, Molashenko NV, Troshina EA, Romanova NY, Kolesnikova GS. Aldosterone- and cortisol-co-secreting adrenal tumors: an uneasy sum of well-known parts (review). Problems of Endocrinology. 2019. doi:10.14341/probl10036
BibTeX
@article{Shifman2019,
author = {Shifman, B M and Platonova, N M and Molashenko, N V and Troshina, E A and Romanova, N Y and Kolesnikova, G S},
title = {Aldosterone- and cortisol-co-secreting adrenal tumors: an uneasy sum of well-known parts (review)},
journal = {Problems of Endocrinology},
year = {2019},
doi = {10.14341/probl10036}
}
EUVIMED